Adrián Dante De Angelis/LinkedIn
Oct 21, 2026, 09:30
Adrián Dante De Angelis: Research That Opens New Possibilities for Recurrent iTTP
Adrián Dante De Angelis, Hematologist at Spital STS AG, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Immunology, adding:
“I am truly happy to be able to share our publication in Frontiers and, above all, to be able to offer new treatment options to this small group of patients with iTTP and multiple relapses.”
Title: Case Report: Zanubrutinib for refractory immune thrombotic thrombocytopenic purpura
Authors: Adrián Dante De Angelis, Annatina Schnegg-Kaufmann, Elisavet Moutzouri, Katarzyna Aleksandra Jalowiec, Milos Ratknic, Johanna A. Kremer Hovinga, Ioannis Chanias
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 10:33Karen Schreiber: Beyond Clinical Outcomes – The Voices of Women with APS
-
Oct 21, 2026, 10:11Tau Braun: Clots Through the Copper-Zinc Model
-
Oct 21, 2026, 09:55Cristina Figueroa Villalba: Celebrating Excellence in Transfusion Medicine
-
Oct 21, 2026, 09:43Ahmad Gharehbaghian: How Can Blood Supplies Be Sustained During a Crisis?
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis
-
Oct 21, 2026, 08:21Pham Quy: Taking Stroke Awareness Beyond Hospitals and Into the Community
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis